Galipeau presents on Xerostomia study at ARM on the MESA meeting
Accompanied by UW School of Medicine and Public Health physician scholars Sara McCoy and Randall Kimple, Jacques Galipeau presented on October 7th at Alliance for Regenerative Medicine on the MESA meeting in Phoenix the results …
October 15, 2024McDowell becomes inaugural Honorary Fellow of Regulatory Affairs
Kimberly McDowell PhD is the inaugural Honorary Fellow of Regulatory Affairs as of October 1 2024, having retired as Director following five years of glorious service with UW Program for Advanced Cell Therapy. Dr. McDowell …
October 15, 2024UW PACT Recruiting for Regulatory Scientist
UW Program for Advanced Cell Therapy has an open position for a Regulatory Scientist. Join a dynamic team led by Jacques Galipeau pushing forward innovative cell therapies for cancer survivors and other disorders. Interested candidates …
July 15, 2024UW Program for Advanced Cell Therapy (PACT) secures new FDA IDE to restore innate immunity post allogeneic BMT
On July 2 2024 FDA CBER approved the PACT-sponsored Investigational Device Exemption (IDE) application # 30707 named “Allogeneic, TCR αβ and CD19+ cell-depleted peripheral blood mononuclear cells”. Allogeneic BMT patients receiving post-transplant cyclophosphamide to reduce risk …
July 15, 2024PACT Completes Pilot Study of Second Dose of MSC for Dry Mouth
UW Program for Advanced Cell Therapy milestone met of sixth and last pilot study (NCT04489732) subject receiving a second administration of autologous MSC in salivary gland to treat radiation-induced dry mouth. In this pilot study, …
May 24, 2024- More News
Integrated personalized cell technologies for improving health outcomes in children and adults